PTC Therapeutics presents new Sephience data
PTC Therapeutics says new Sephience (sepiapterin) data reinforce sustained metabolic control, diet liberalization and a consistent favorable safety profile.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.